// App-Quantinova.ai

9086 : Real-world outcomes and clinical characteristics of patients with brain metastases from EGFR mutated non-small cell lung cancer: Data from a large retrospective study (REFLECT).

Researchers

Presenter

  • Urska Janzic

Principal Investigators

  • Alfredo Addeo

  • Elizabeth Dudnik

  • Andriani Charpidou

  • Adam Pluzanski

  • Tudor-Eliade Ciuleanu

  • Ivan Donev

  • Una Rigney

  • Judith Elbaz

  • Jorgen Aaroe

  • Nir Peled

  • Maximilian Hochmair

Medical Centers

  • Centre of Oncology, Geneva University Hospital, Geneva, Switzerland

  • Thoracic Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva/IL

  • Laikon General Hospital, First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece

  • Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland

  • Prof Dr Ion Chiricuta Oncology Institute and Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

  • Department of Medical Oncology, Nadezhda Hospital, Sofia, Bulgaria

  • AstraZeneca, Royston, United Kingdom

  • AstraZeneca Israel

  • Hod Hasharon, Israel

  • AstraZeneca Norway

  • Oslo, Norway

  • Clalit Health Services, Soroka Medical Center, Beer-Sheeva, Israel

  • Karl- Landsteiner-Institute for Lung Research and Pulmonary Oncology, Vienna, Austria

Locations

  • Slovenia

  • Switzerland

  • Israel

  • Greece

  • Poland

  • Romania

  • Bulgaria

  • United Kingdom

  • Norway

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Brain metastasis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • Tagrisso

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT04031898

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved